152 related articles for article (PubMed ID: 38031210)
1. The usage of Gellhorn pessary in pelvic organ prolapse and in regards to success, continuity of use and effect on symptoms: a retrospective study of 2 years.
Ramanujam S; Balakrishnan S
Med J Malaysia; 2023 Nov; 78(6):705-710. PubMed ID: 38031210
[TBL] [Abstract][Full Text] [Related]
2. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
[TBL] [Abstract][Full Text] [Related]
3. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
Yang J; Han J; Zhu F; Wang Y
Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with pessary fitting in women with symptomatic pelvic organ prolapse: A large prospective cohort study.
Ma C; Xu T; Kang J; Zhang Y; Ma Y; Liang S; Zhu L
Neurourol Urodyn; 2020 Nov; 39(8):2238-2245. PubMed ID: 32936968
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
[TBL] [Abstract][Full Text] [Related]
6. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
Deng M; Ding J; Ai F; Zhu L
Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
[TBL] [Abstract][Full Text] [Related]
7. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
[TBL] [Abstract][Full Text] [Related]
8. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
Ding J; Song XC; Deng M; Zhu L
Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
[TBL] [Abstract][Full Text] [Related]
9. Effect of generalized anxiety disorders on the success of pessary treatment for pelvic organ prolapse.
Ai FF; Mao M; Zhang Y; Kang J; Zhu L
Int Urogynecol J; 2018 Aug; 29(8):1147-1153. PubMed ID: 29478112
[TBL] [Abstract][Full Text] [Related]
10. Pessaries (mechanical devices) for managing pelvic organ prolapse in women.
Bugge C; Adams EJ; Gopinath D; Stewart F; Dembinsky M; Sobiesuo P; Kearney R
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004010. PubMed ID: 33207004
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.
Barber MD; Walters MD; Cundiff GW;
Am J Obstet Gynecol; 2006 May; 194(5):1492-8. PubMed ID: 16647933
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
[TBL] [Abstract][Full Text] [Related]
13. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
Xu H; Wu W; Wang X; Xia Z
Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
[TBL] [Abstract][Full Text] [Related]
14. Vaginal Pessaries for Pelvic Organ Prolapse or Stress Urinary Incontinence: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(3):1-155. PubMed ID: 34055111
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported goal achievements after pelvic floor muscle training versus pessary in women with pelvic organ prolapse. A randomised controlled trial.
Limbutara W; Bunyavejchevin S; Ruanphoo P; Chiengthong K
J Obstet Gynaecol; 2023 Dec; 43(1):2181061. PubMed ID: 36803636
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of a novel, collapsible pessary for management of pelvic organ prolapse.
Strohbehn K; Wadensweiler PM; Richter HE; Grimes CL; Rardin CR; Rosenblatt PL; Toglia MR; Siddiqui G; Hanissian P
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38761837
[TBL] [Abstract][Full Text] [Related]
17. Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.
Wolff B; Williams K; Winkler A; Lind L; Shalom D
Int Urogynecol J; 2017 Jul; 28(7):993-997. PubMed ID: 27942793
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes of Self-Management Gellhorn Pessary for Symptomatic Pelvic Organ Prolapse.
Chien CW; Lo TS; Tseng LH; Lin YH; Hsieh WC; Lee SJ
Female Pelvic Med Reconstr Surg; 2020 Nov; 26(11):e47-e53. PubMed ID: 31393340
[TBL] [Abstract][Full Text] [Related]
19. Depressive symptoms affect outcomes of pessary use in postmenopausal women with uterine prolapse.
Ai FF; Zhu L; Mao M; Zhang Y; Kang J
Climacteric; 2018 Apr; 21(2):184-188. PubMed ID: 29397780
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of pessary fitting trials for patients with stage IV pelvic organ prolapse: a prospective study.
Zhou Y; Sun T; Ju A; Zhu L
Int Urogynecol J; 2024 Jan; 35(1):59-67. PubMed ID: 37542565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
